Lymphokine-activated killer cell and nat
โ
Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 499 KB
๐ 2 views
Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr